Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 17, 2012BloodOpen Access

JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone

View Full Paper
Ask AI
Bookmark
Share

Authors

AGAnna L. GodfreyCambridge University Hospitals NHS Foundation TrustECEdwin ChenUniversity of British ColumbiaFPFrancesca PaganoInstitute of Cell Biology and Neurobiology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Godfrey et al. (2012) studied this question.

synapsesocial.com/papers/6a20a6563ff902933291db59https://doi.org/10.1182/blood-2012-05-431791
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis2007 · 106 citations
  2. 2Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations2008 · 108 citations
  3. 3A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders2005 · 3,496 citations
  4. 4Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice2007 · 447 citations
  5. 5JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis2007 · 1,273 citations